Akebia Therapeutics to Present at Upcoming Investor Conferences GlobeNewswire November 04, 2025 CAMBRIDGE, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) — Akebia Therapeutics(R), Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, Chief Executive Officer, and Erik Ostrowski, Chief Financial […]

Medidata Expands Collaboration with CTI Clinical Trial and Consulting, Shaping a New Era of Patient-Centric Studies Medidata Patient Experience will accelerate CTI's treatments for patients with oncology, metabolic, cardiovascular, central nervous system, and immune conditions GlobeNewswire November 04, 2025 NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) — Medidata, a Dassault Systemes brand and leading provider

GraniteShares launches new YieldBOOSTTM ETFs on MARA (MAAY) and IONQ (IOYY). GlobeNewswire November 04, 2025 New York, NY, Nov. 04, 2025 (GLOBE NEWSWIRE) — GraniteShares, an ETF issuer specializing in high conviction ETFs, announced that it is launching two ETFs to add to its existing YieldBOOSTTM lineup – the GraniteShares YieldBOOSTTM MARA ETF (MAAY) and

Majority of Canada's drivers prioritize safety amid harsher winters despite rising cost of living: survey Three quarters say extreme weather patterns make winter tires more important than ever GlobeNewswire November 04, 2025 TORONTO, Nov. 04, 2025 (GLOBE NEWSWIRE) — Three quarters of Canadian motorists (76 per cent) believe extreme winter weather events related to Canada's

Certara Automates Scientific Workflows with Phoenix(R) Cloud New cloud capabilities cut time to create Tables, Figures, and Listings by 50% GlobeNewswire November 04, 2025 RADNOR, Pa., Nov. 04, 2025 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of TFL Studio, the first cloud-native module of

Jasper Therapeutics to Present at Upcoming Investor Conferences GlobeNewswire November 04, 2025 REDWOOD CITY, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting KIT (CD117) to address mast cell driven diseases such as chronic spontaneous urticaria

National Committee for Quality Assurance (NCQA) Renews Healthmap Solutions' Population Health Program Accreditation GlobeNewswire November 04, 2025 TAMPA, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) — Healthmap Solutions, Inc. (Healthmap) announced today that it has earned a three-year renewal of its NCQA Population Health Program Accreditation for its Kidney Population Health Management program. Healthmap Chief Medical

Northern Technologies International Corporation Secures Multi-Year Offshore Oil & Gas Production Asset Preservation Contract in Brazil GlobeNewswire November 04, 2025 MINNEAPOLIS, Nov. 04, 2025 (GLOBE NEWSWIRE) — Northern Technologies International Corporation (NASDAQ: NTIC), a leading developer of corrosion inhibiting products and services, as well as bio-based and biodegradable polymer resin compounds, today announced that its

BrainsWay Reports National Institutes of Health Grant to Leading U.S. Research Team Investigating Accelerated Deep TMS for Treatment of Alcohol Use Disorder New NIH grant awards $2.5 million over 5 years for mechanistic study GlobeNewswire November 04, 2025 BURLINGTON, Mass. and JERUSALEM, Nov. 04, 2025 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”

Vortex Energy Corp. Announces Submission of Abstract for Presentation at the 2026 Canadian Hydrogen Convention University of Alberta-led research highlights emerging hydrogen storage potential at Robinsons River Salt Dome GlobeNewswire November 04, 2025 VANCOUVER, British Columbia, Nov. 04, 2025 (GLOBE NEWSWIRE) — Vortex Energy Corp. (CSE: VRTX) (OTC: VTECF) (FSE: AA3) (“Vortex” or the “Company“)